Whitepaper: Biomarkers and mechanisms of toxicity
Posted: 23 February 2021 | Eurofins Discovery | No comments yet
Phenotypic profiling identifies biomarkers and mechanisms of toxicity.
Small animal models such as mice and rats are poor predictors of skin reactions in humans. Until candidates are tested in expensive human safety trials or in non-human primate models, potential skin reactions are difficult to predict. The BioMAP® Phenotypic Profiling Platform provides a robust and reliable alternative path to the resource-heavy traditions of animal testing and conventional preclinical procedures.
Related content from this organisation
- Unprecedented fragment-based screening using Spectral Shift for GPCRs
- Rapid functional cell-based activity profiling of multi-receptor targeted anti-obesity therapies
- CRISPR™ MDCKII cell lines development for bioavailability and DDI assessments
- SAFIRE: AI predicted ADME for drug discovery: leveraging BioPrint
- Biophysics in kinase drug discovery: FBS to PROTAC® ternary complex characterisation
Related topics
Assays, Biopharmaceuticals, Disease Research, Hit-to-Lead, Screening, Targets
Related organisations
Eurofins Discovery
